Furthermore, TBK1 activity is selectively essential for the survival of cancer cells with mutant KRAS, identified in a systematic synthetic lethal RNAi screening in NCI-H23 cells, a lung cancer cell line expressing mutant KRAS (Barbie et al., 2009). The gene discussed is TBK1; the disease is lung carcinoma.